SCHEMBL6170455

SCHEMBL6170455

O=C(O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2CC(=O)C(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.56
NR4A2 P43354 1/20 0.56
MT-CO2 P00403 3/20 0.52
PTGS1 P23219 5/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
LMNA P02545 1/20 0.43
CA3 P07451 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
ADRA2B P18089 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
SLC6A2 P23975 1/20 0.43
PDE4A P27815 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4885453 0.86 PTGS2 (0.69) PTGS2NR4A2MT-CO2PTGS1CA12
SCHEMBL5073588 0.79 PTGS2 (0.81) PTGS2NR4A2MT-CO2PTGS1CA12
SCHEMBL8478348 0.78 ALDH1A1 (0.45) PTGS2NR4A2MT-CO2ALDH1A1PKM
SCHEMBL5069853 0.76 PTGS2 (0.67) PTGS2NR4A2MT-CO2PTGS1CA12
SCHEMBL14340629 0.75 PTGS2 (0.78) PTGS2NR4A2MT-CO2PTGS1CA12
SCHEMBL5069870 0.74 PTGS2 (0.77) PTGS2NR4A2MT-CO2PTGS1CA12
SCHEMBL8478699 0.74 PTGS2 (0.47) PTGS2MT-CO2PTGS1CA12CA1
SCHEMBL4881634 0.73 PTGS2 (0.77) PTGS2MT-CO2PTGS1CA12CA1
SCHEMBL6170017 0.73 PTGS2 (0.63) PTGS2MT-CO2PTGS1PDE3A
SCHEMBL5698463 0.73 PTGS2 (0.63) PTGS2MT-CO2PTGS1PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed